Monoclonal antibody
Type Whole antibody
Source Human
Target CD221
Clinical data
ATC code none
CAS Number 934235-44-6 N
ChemSpider none
UNII V983921H3B YesY
KEGG D10056 N
Chemical and physical data
Formula C6418H9960N1732O1992S42
Molar mass 144.6 kg/mol
 NYesY (what is this?)  (verify)

Robatumumab (proposed INN) is a monoclonal antibody and an antineoplastic by Schering-Plough. It binds to CD221, the insulin-like growth factor 1 receptor.[1]


  1. International Nonproprietary Names for Pharmaceutical Substances (INN, prepublication copy), World Health Organization.

This article is issued from Wikipedia - version of the 9/21/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.